4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Organogenesis Holdings Inc. (ORGO) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Canton, United States with about 854 employees. Its market capitalization is roughly $337 million. In the fiscal year ended 2025-12-31, ORGO reported $563M in revenue and $37M in net income.
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
Interactive charts & full statements → Open the ORGO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $563M | $482M | $433M | $451M | — |
| Gross Profit | $426M | $366M | $327M | $346M | — |
| Operating Income (EBIT) | $56M | $22M | $12M | $22M | — |
| Net Income | $37M | $1M | $5M | $16M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $36M | $225M | $150M | $101M | $87M | — |
| Gross Profit | $10M | $175M | $114M | $73M | $63M | — |
| Operating Income (EBIT) | ($69M) | $65M | $22M | ($11M) | ($20M) | — |
| Net Income | ($53M) | $44M | $22M | ($9M) | ($19M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $599M | $498M | $460M | $449M | — |
| Total Liabilities | $165M | $113M | $181M | $184M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ORGO viewer.
About TickerBase · Data methodology & sources